ETS1 and breast carcinoma: Using cell lysates obtained from the breast cancer cell line MDA-MB-231 as a positive control, the antibody was found to specifically detect phospho-ETS1 Thr265, Ser269 both in the absence and presence of the control peptide (i.e., without phosphorylated residues).